Began Marc A's Form 4 filing
Abiomed Inc (ABMD) · filed Nov 8, 2022
- Accession no.
- 0001415889-22-011186
- Filed
- Nov 8, 2022
- Trade date
- Nov 4-5, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $747.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Began Marc ACIK 0001821352 | Officer (VP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −2,000 | $373.71 | −$747,420 | 13,785 | Direct | |
| Nov 5, 2022 | Common Stock, $0.01 par value | FTax withholdingDisposed | −1,548 | $373.99 | −$578,936.52 | 12,237 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.